KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2020
2020
Related Segments
US Digital Pathology 2022
Early Adopters Lead the Charge in an Emerging Market
Author
Eder Lagemann
Author
Sidney Tate
Digital pathology for primary diagnosis is nascent in the US, but it is primed for rapid growth, similar to what is currently being seen in Europe (see KLAS’ report on global digital pathology). In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. 33 of the interviewed organizations are live with digital pathology; the rest are currently implementing or making plans for the future.
If you don't have a login, getting started is easy.
Key Findings:
- State of Digital Pathology among Early US Adopters
- Digital Pathology Technology Use
- Leica, Philips Lead in Busy IMS Market
- Leica & Philips Scanners Selected Most Frequently with Own IMS; Hamamatsu, Roche & 3DHISTECH Most Common for Third-Party Pairings
Writer
Elizabeth Pew
Designer
Madison Moniz
Project Manager
Jill Wilcock
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.